| General Information of Drug Metabolite (DM) (ID: DM018165) |
| DM Name |
SRI-62-834 Metabolite M1
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Choline phosphatase 1 (PLD1)
|
DME0194
|
| Unclear - Unclear |
SRI-62-834
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| SRI-62-834 |
DR3024
|
Discontinued in Phase 2 |
Solid tumour/cancer |
|
|
| References |
| 1 |
Is metabolism an important arbiter of anticancer activity of ether lipids? Metabolism of SRI 62-834 and hexadecylphosphocholine by [31P]-NMR spectroscopy and comparison of their cytotoxicities with those of their metabolites
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
